Biomarkers Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4166079
- 91 Pages
- January 2021
- Diagnostic and Biotech
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Biomarkers market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Biomarkers market segmented into
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Others
Based on the end-use, the global Biomarkers market classified into
Diagnostics
Drug Discovery
Personalized Medicine
Others
Based on geography, the global Biomarkers market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott
Agilent Technologies
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BIOMARKERS INDUSTRY
2.1 Summary about Biomarkers Industry
2.2 Biomarkers Market Trends
2.2.1 Biomarkers Production & Consumption Trends
2.2.2 Biomarkers Demand Structure Trends
2.3 Biomarkers Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Sepsis Biomarkers
4.2.2 Antibiotic Resistance Biomarkers
4.2.3 Traumatic Brain Injury (TBI) Testing Biomarkers
4.2.4 Stroke Testing Biomarkers
4.2.5 Antibiotic Stewardship Biomarkers
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Diagnostics
4.3.2 Drug Discovery
4.3.3 Personalized Medicine
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Sepsis Biomarkers
5.2.2 Antibiotic Resistance Biomarkers
5.2.3 Traumatic Brain Injury (TBI) Testing Biomarkers
5.2.4 Stroke Testing Biomarkers
5.2.5 Antibiotic Stewardship Biomarkers
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Diagnostics
5.3.2 Drug Discovery
5.3.3 Personalized Medicine
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Sepsis Biomarkers
6.2.2 Antibiotic Resistance Biomarkers
6.2.3 Traumatic Brain Injury (TBI) Testing Biomarkers
6.2.4 Stroke Testing Biomarkers
6.2.5 Antibiotic Stewardship Biomarkers
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Diagnostics
6.3.2 Drug Discovery
6.3.3 Personalized Medicine
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Sepsis Biomarkers
7.2.2 Antibiotic Resistance Biomarkers
7.2.3 Traumatic Brain Injury (TBI) Testing Biomarkers
7.2.4 Stroke Testing Biomarkers
7.2.5 Antibiotic Stewardship Biomarkers
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Diagnostics
7.3.2 Drug Discovery
7.3.3 Personalized Medicine
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Sepsis Biomarkers
8.2.2 Antibiotic Resistance Biomarkers
8.2.3 Traumatic Brain Injury (TBI) Testing Biomarkers
8.2.4 Stroke Testing Biomarkers
8.2.5 Antibiotic Stewardship Biomarkers
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Diagnostics
8.3.2 Drug Discovery
8.3.3 Personalized Medicine
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Sepsis Biomarkers
9.2.2 Antibiotic Resistance Biomarkers
9.2.3 Traumatic Brain Injury (TBI) Testing Biomarkers
9.2.4 Stroke Testing Biomarkers
9.2.5 Antibiotic Stewardship Biomarkers
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Diagnostics
9.3.2 Drug Discovery
9.3.3 Personalized Medicine
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Thermo Fisher Scientific
10.1.2 Merck
10.1.3 Bio-Rad Laboratories
10.1.4 QIAGEN
10.1.5 Roche
10.1.6 Danaher Corporation
10.1.7 Siemens Healthcare
10.1.8 Abbott
10.1.9 Agilent Technologies
10.2 Biomarkers Sales Date of Major Players (2017-2020e)
10.2.1 Thermo Fisher Scientific
10.2.2 Merck
10.2.3 Bio-Rad Laboratories
10.2.4 QIAGEN
10.2.5 Roche
10.2.6 Danaher Corporation
10.2.7 Siemens Healthcare
10.2.8 Abbott
10.2.9 Agilent Technologies
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Biomarkers Product Type Overview
2.Table Biomarkers Product Type Market Share List
3.Table Biomarkers Product Type of Major Players
4.Table Brief Introduction of Thermo Fisher Scientific
5.Table Brief Introduction of Merck
6.Table Brief Introduction of Bio-Rad Laboratories
7.Table Brief Introduction of QIAGEN
8.Table Brief Introduction of Roche
9.Table Brief Introduction of Danaher Corporation
10.Table Brief Introduction of Siemens Healthcare
11.Table Brief Introduction of Abbott
12.Table Brief Introduction of Agilent Technologies
13.Table Products & Services of Thermo Fisher Scientific
14.Table Products & Services of Merck
15.Table Products & Services of Bio-Rad Laboratories
16.Table Products & Services of QIAGEN
17.Table Products & Services of Roche
18.Table Products & Services of Danaher Corporation
19.Table Products & Services of Siemens Healthcare
20.Table Products & Services of Abbott
21.Table Products & Services of Agilent Technologies
22.Table Market Distribution of Major Players
23.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
24.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
25.Table Global Biomarkers Market Forecast (Million USD) by Region 2021f-2026f
26.Table Global Biomarkers Market Forecast (Million USD) Share by Region 2021f-2026f
27.Table Global Biomarkers Market Forecast (Million USD) by Demand 2021f-2026f
28.Table Global Biomarkers Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
